EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Cervical Cancer|Head and Neck Cancer|Prostate Cancer|Sarcoma
Interventions: DRUG: EF5|OTHER: flow cytometry|OTHER: fluorescent antibody technique|OTHER: immunohistochemistry staining method|PROCEDURE: biopsy
Sponsor: University Health Network, Toronto
Collaborators: National Cancer Institute (NCI)